TWI925859B - 抗血小板藥物及其用途 - Google Patents
抗血小板藥物及其用途Info
- Publication number
- TWI925859B TWI925859B TW110127818A TW110127818A TWI925859B TW I925859 B TWI925859 B TW I925859B TW 110127818 A TW110127818 A TW 110127818A TW 110127818 A TW110127818 A TW 110127818A TW I925859 B TWI925859 B TW I925859B
- Authority
- TW
- Taiwan
- Prior art keywords
- compound
- pharmaceutically acceptable
- alkyl
- group
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| WOPCT/CN2020/105513 | 2020-07-29 | ||
| CN2020105513 | 2020-07-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW202214609A TW202214609A (zh) | 2022-04-16 |
| TWI925859B true TWI925859B (zh) | 2026-05-21 |
Family
ID=80037185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW110127818A TWI925859B (zh) | 2020-07-29 | 2021-07-29 | 抗血小板藥物及其用途 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US12410132B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4342532B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7899159B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR102906376B1 (cg-RX-API-DMAC7.html) |
| CN (4) | CN119552111B (cg-RX-API-DMAC7.html) |
| AR (1) | AR123078A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021317436A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023001595A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3186645A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3046366T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL299979A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023001232A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI925859B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022022559A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202339745A (zh) * | 2022-01-28 | 2023-10-16 | 大陸商上海柯君醫藥科技有限公司 | 抗血小板藥物的藥物組合物及其用途 |
| CN116813532B (zh) * | 2023-06-29 | 2026-05-15 | 上海柯君医药科技有限公司 | 一种哌啶化合物的制备方法 |
| WO2025108307A1 (zh) | 2023-11-24 | 2025-05-30 | 上海柯君医药科技有限公司 | 一种含哌啶环化合物的苯磺酸盐、其制备方法及应用 |
| WO2025108300A1 (zh) | 2023-11-24 | 2025-05-30 | 上海柯君医药科技有限公司 | 一种含哌啶环化合物的苯磺酸盐的晶型、其制备方法及应用 |
| CN119019320B (zh) * | 2024-10-29 | 2025-03-11 | 上海柯君医药科技有限公司 | 一种具有抗血小板活性的哌啶类化合物的制备方法 |
| CN119176829B (zh) * | 2024-11-26 | 2025-04-15 | 上海柯君医药科技有限公司 | 一种哌啶环化合物的制备方法 |
| CN119192061B (zh) * | 2024-11-28 | 2025-05-13 | 上海柯君医药科技有限公司 | 一种含哌啶环的化合物的纯化方法 |
| CN119371453A (zh) * | 2024-12-30 | 2025-01-28 | 上海柯君医药科技有限公司 | 一种抗血小板药物中间体的制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998008811A1 (en) * | 1996-08-28 | 1998-03-05 | Sankyo Company, Limited | Cyclic amine derivatives |
| CN106554368A (zh) * | 2015-09-25 | 2017-04-05 | 陕西合成药业股份有限公司 | 噻吩并吡啶类衍生物及其制备方法和用途 |
| CN106554303A (zh) * | 2015-09-25 | 2017-04-05 | 陕西合成药业股份有限公司 | 噻吩并吡啶类衍生物及其制备方法和用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2570048A1 (en) * | 2004-07-07 | 2006-01-12 | Medicure International Inc. | Combination therapies employing platelet aggregation drugs |
| CN104379589A (zh) * | 2012-05-07 | 2015-02-25 | 塞利克斯比奥私人有限公司 | 抗血小板药剂的前药 |
| CA2880898A1 (en) * | 2012-08-03 | 2014-02-06 | Bristol-Myers Squibb Company | Dihydropyridone p1 as factor xia inhibitors |
| CN103626694A (zh) * | 2012-08-29 | 2014-03-12 | 中国药科大学 | 不饱和环胺衍生物、其制备方法及其医药用途 |
| NO2721243T3 (cg-RX-API-DMAC7.html) * | 2014-10-01 | 2018-10-20 | ||
| CN119019320B (zh) * | 2024-10-29 | 2025-03-11 | 上海柯君医药科技有限公司 | 一种具有抗血小板活性的哌啶类化合物的制备方法 |
| CN119192061B (zh) * | 2024-11-28 | 2025-05-13 | 上海柯君医药科技有限公司 | 一种含哌啶环的化合物的纯化方法 |
-
2021
- 2021-07-28 CN CN202411716601.2A patent/CN119552111B/zh active Active
- 2021-07-28 MX MX2023001232A patent/MX2023001232A/es unknown
- 2021-07-28 EP EP24156405.3A patent/EP4342532B1/en active Active
- 2021-07-28 KR KR1020257016343A patent/KR102906376B1/ko active Active
- 2021-07-28 IL IL299979A patent/IL299979A/en unknown
- 2021-07-28 ES ES24156405T patent/ES3046366T3/es active Active
- 2021-07-28 CA CA3186645A patent/CA3186645A1/en active Pending
- 2021-07-28 CN CN202410873004.4A patent/CN119033782B/zh active Active
- 2021-07-28 BR BR112023001595A patent/BR112023001595A2/pt unknown
- 2021-07-28 CN CN202311275197.5A patent/CN117343000A/zh active Pending
- 2021-07-28 WO PCT/CN2021/108875 patent/WO2022022559A1/en not_active Ceased
- 2021-07-28 JP JP2023506150A patent/JP7899159B2/ja active Active
- 2021-07-28 US US18/018,576 patent/US12410132B2/en active Active
- 2021-07-28 EP EP21851193.9A patent/EP4188935A4/en active Pending
- 2021-07-28 KR KR1020237007048A patent/KR20230047425A/ko not_active Ceased
- 2021-07-28 CN CN202180058245.8A patent/CN116194459A/zh active Pending
- 2021-07-28 AU AU2021317436A patent/AU2021317436A1/en active Pending
- 2021-07-29 AR ARP210102107A patent/AR123078A1/es unknown
- 2021-07-29 TW TW110127818A patent/TWI925859B/zh active
-
2025
- 2025-07-08 US US19/262,108 patent/US20250333382A1/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998008811A1 (en) * | 1996-08-28 | 1998-03-05 | Sankyo Company, Limited | Cyclic amine derivatives |
| CN106554368A (zh) * | 2015-09-25 | 2017-04-05 | 陕西合成药业股份有限公司 | 噻吩并吡啶类衍生物及其制备方法和用途 |
| CN106554303A (zh) * | 2015-09-25 | 2017-04-05 | 陕西合成药业股份有限公司 | 噻吩并吡啶类衍生物及其制备方法和用途 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN116194459A (zh) | 2023-05-30 |
| KR20230047425A (ko) | 2023-04-07 |
| IL299979A (en) | 2023-03-01 |
| TW202214609A (zh) | 2022-04-16 |
| JP7899159B2 (ja) | 2026-08-03 |
| CN119033782A (zh) | 2024-11-29 |
| KR20250073569A (ko) | 2025-05-27 |
| MX2023001232A (es) | 2023-05-15 |
| US20250333382A1 (en) | 2025-10-30 |
| EP4342532C0 (en) | 2025-09-03 |
| US20240279178A1 (en) | 2024-08-22 |
| AU2021317436A1 (en) | 2023-02-23 |
| ES3046366T3 (en) | 2025-12-01 |
| CN119552111A (zh) | 2025-03-04 |
| CA3186645A1 (en) | 2022-02-03 |
| EP4342532B1 (en) | 2025-09-03 |
| CN119552111B (zh) | 2026-01-02 |
| EP4188935A1 (en) | 2023-06-07 |
| KR102906376B1 (ko) | 2025-12-30 |
| AR123078A1 (es) | 2022-10-26 |
| WO2022022559A1 (en) | 2022-02-03 |
| CN119033782B (zh) | 2025-04-25 |
| US12410132B2 (en) | 2025-09-09 |
| EP4342532A3 (en) | 2024-07-17 |
| EP4188935A4 (en) | 2024-07-17 |
| EP4342532A2 (en) | 2024-03-27 |
| BR112023001595A2 (pt) | 2023-04-04 |
| CN117343000A (zh) | 2024-01-05 |
| JP2023535815A (ja) | 2023-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4172216A4 (en) | BIFUNCTIONAL SUPERKINE AND USES THEREOF | |
| IL299979A (en) | Antiplatelet drugs and their uses | |
| EP4305030A4 (en) | HETEROCYCLES AND THEIR USES | |
| EP4096651A4 (en) | COMPOUNDS AND THEIR USES | |
| EP4096668A4 (en) | COMPOUNDS AND USES THEREOF | |
| EP4096664A4 (en) | COMPOUNDS AND USES THEREOF | |
| EP4215208A4 (en) | PHARMACEUTICAL COMBINATION AND USE THEREOF | |
| EP4165049A4 (en) | ISOTRYPTAMIN PSYCOPLASTIOGENS AND USES THEREOF | |
| EP4247815A4 (en) | COMPOUNDS AND USES THEREOF | |
| EP4037670A4 (en) | 5-FLUORONICOTINAMIDE DERIVATIVES AND USES THEREOF | |
| EP4233882A4 (en) | Mitochondria comprising anticancer drug and use thereof | |
| EP4326340A4 (en) | MODIFIED POLYPEPTIDES AND THEIR USES | |
| EP4337211A4 (en) | COMPOUNDS AND THEIR USES | |
| EP4140480A4 (en) | DRUG COMBINATION AND USE | |
| EP4342492A4 (en) | PHARMACEUTICAL COMBINATION AND ITS USE | |
| EP4129282A4 (en) | PHARMACEUTICAL ASSOCIATION AND ITS USE | |
| HK40081165A (en) | Pharmaceutical combination comprising tno155 and nazartinib | |
| HK40108849A (en) | Nitrophenyl-acrylamides and uses thereof | |
| HK40103610A (en) | Pharmaceutical combination and use thereof | |
| HK40102892A (en) | Heterocycles and uses thereof | |
| AU2020900439A0 (en) | Tpv-2l variants and uses thereof | |
| HK40084386A (en) | Substituted pyrazolo-pyrimidines and uses thereof | |
| HK40115119A (en) | Lilrb polypeptides and uses thereof | |
| HK40107538A (en) | Staple-containing polypeptides and application thereof | |
| HK40109989A (en) | Nkp46-binding polypeptides and uses thereof |